Posts

PRESS RELEASE: Microbiome Insights receives funding from the Government of Canada to develop new microbiome testing platform for managing chronic disease

Vancouver, British Columbia (September 12, 2018)—Microbiome Insights, Inc. is pleased to announce that it will receive a contribution of up to $190,249 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to help support the development of a new personal health platform of microbiome testing.

Co-founded by Drs. Brett Finlay and Bill Mohn at University of British Columbia in 2015, Microbiome Insights is a rapidly growing company and a global leader in microbiome testing and bioinformatic analysis. The advisory services and financial assistance from the Government of Canada, through NRC IRAP, will help the company expand in a new direction—continuing to develop tools for use in clinical settings as new data emerge on the gut microbiome and health.

“We’re leveraging our expertise in microbiome testing to develop a suite of tools for monitoring chronic disease in clinical practice,” says Microbiome Insights CEO Malcolm Kendall. “From the practitioner interface to the educational components of the test, our team is taking a fresh approach that is going to change the game for microbiome testing.”

The primary aim of the company’s personal health platform is to help address the challenges both healthcare practitioners and individuals face in the management of chronic disease.  Microbiome monitoring in those with chronic disease may provide a tool for assessing response to therapies or to various lifestyle changes (including diet), particularly when integrated with robust research findings and ongoing data collection.

The company’s new testing platform will be aimed at health practitioners helping individuals who live with inflammatory bowel disease. The efforts are led by Nataša Jovic, MBA, who brings to the company twenty years of experience in therapeutic and diagnostic commercialization. The company is currently exploring opportunities to commercialize its platform of microbiome tests for healthcare practitioners through research collaborations and distribution or joint commercialization efforts.

See the original BusinessWire press release here.

Events

Skin Microbiome Congress

Join Microbiome Insights, Inc. at the Skin Microbiome Congress, where they will be presenting as well as attending as event partners. Researchers and industry leaders are increasingly taking notice of the emerging relationship between skin health and the skin microbiome, with a push toward more ‘natural’ products. Therefore, the potential to harness skin bacteria to treat various conditions is an enormous opportunity. Held in Boston, MA (USA) on May 30-31, the Skin Microbiome Congress brings together over 100 industry experts from leading multinational pharmaceutical, beauty, and personal care companies, along with independent skin care brands and innovative biotechs advancing the field. Attendees will learn about cutting edge research, consumer trends, how to design effective clinical trials, gaining a competitive edge for their product lines, and understanding the many avenues toward market and regulatory considerations. Don’t miss a chance to network with and learn from colleagues in the field — including proud event partners, Microbiome Insights.